Atypical femoral fractures and their relation to bisphosphonate use

Isr Med Assoc J. 2013 Aug;15(8):447-50.
No abstract available

Publication types

  • Review

MeSH terms

  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / adverse effects*
  • Bone Density Conservation Agents / therapeutic use
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects*
  • Diphosphonates / therapeutic use
  • Femoral Fractures / etiology*
  • Femoral Fractures / pathology
  • Humans
  • Osteoporosis / complications
  • Osteoporosis / drug therapy
  • Time Factors

Substances

  • Bone Density Conservation Agents
  • Diphosphonates